
|
|  | |
|
Am J Psychiatry 1990; 147:602-607
Copyright © 1990 by American Psychiatric Association
Suicide and schizophrenia: data from a prospective community treatment study [published erratum appears in Am J Psychiatry 1990 Aug;147(8):1110]
LJ Cohen, MA Test and RL Brown
Department of Psychiatry, School of Social Work, University of Wisconsin-Madison 53706.
This article reports the analysis of prospectively gathered data on eight
young adults who committed suicide during an ongoing longitudinal study of
long-term treatment of schizophrenia in the community. Young adult men with
an early onset of psychiatric illness were identified as a high-risk
subgroup. At the time of admission to the study, the subjects who
eventually committed suicide reported significantly more distress and
tended to be less satisfied with their lives than the other subjects.
Specifically, baseline measures of self-reported subjective distress were
consistently predictive of later suicide, whereas interviewer-rated
measures and postbaseline assessments were not.
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Noel
ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders
Am. J. Health Syst. Pharm.,
April 15, 2007;
64(8):
863 - 876.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. HAWTON, L. SUTTON, C. HAW, J. SINCLAIR, and J. J. DEEKS
Schizophrenia and suicide: systematic review of risk factors
The British Journal of Psychiatry,
July 1, 2005;
187(1):
9 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bourgeois, J. Swendsen, F. Young, X. Amador, S. Pini, G. B. Cassano, J.-P. Lindenmayer, C. Hsu, L. Alphs, H. Y. Meltzer, et al.
Awareness of Disorder and Suicide Risk in the Treatment of Schizophrenia: Results of the International Suicide Prevention Trial
Am J Psychiatry,
August 1, 2004;
161(8):
1494 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.J. Lean and F.-G. Pajonk
Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes
Diabetes Care,
May 1, 2003;
26(5):
1597 - 1605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Y. Meltzer, L. Alphs, A. I. Green, A. C. Altamura, R. Anand, A. Bertoldi, M. Bourgeois, G. Chouinard, M. Z. Islam, J. Kane, et al.
Clozapine Treatment for Suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT)
Arch Gen Psychiatry,
January 1, 2003;
60(1):
82 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Y. Meltzer
Treatment of Suicidality in Schizophrenia
Ann. N.Y. Acad. Sci.,
April 1, 2001;
932(1):
44 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Raymont
Suicide in schizophrenia -- how can research influence training and clinical practice?
Psychiatr. Bull.,
February 1, 2001;
25(2):
46 - 50.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. J. Mann, C. Waternaux, G. L. Haas, and K. M. Malone
Toward a Clinical Model of Suicidal Behavior in Psychiatric Patients
Am J Psychiatry,
February 1, 1999;
156(2):
181 - 189.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. H. Littrell and S. H. Littrell
Treatment-refractory Schizophrenia: Update on Concepts and Interventions
Journal of the American Psychiatric Nurses Association,
February 1, 1998;
4(1):
S18 - S28.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1990
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|